Global Biopharmaceutical and Vaccines Market Size, Status and Forecast 2024-2031

Report ID: 917693 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Biopharmaceutical
        1.2.3 Vaccine Production
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical and Vaccines Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Pharmaceuticals Industry
        1.3.3 Clinical Diagnosis
        1.3.4 Scientific Research
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biopharmaceutical and Vaccines Market Perspective (2016-2027)
    2.2 Biopharmaceutical and Vaccines Growth Trends by Regions
        2.2.1 Biopharmaceutical and Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biopharmaceutical and Vaccines Historic Market Share by Regions (2016-2021)
        2.2.3 Biopharmaceutical and Vaccines Forecasted Market Size by Regions (2022-2027)
    2.3 Biopharmaceutical and Vaccines Industry Dynamic
        2.3.1 Biopharmaceutical and Vaccines Market Trends
        2.3.2 Biopharmaceutical and Vaccines Market Drivers
        2.3.3 Biopharmaceutical and Vaccines Market Challenges
        2.3.4 Biopharmaceutical and Vaccines Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceutical and Vaccines Players by Revenue
        3.1.1 Global Top Biopharmaceutical and Vaccines Players by Revenue (2016-2021)
        3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Players (2016-2021)
    3.2 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceutical and Vaccines Revenue
    3.4 Global Biopharmaceutical and Vaccines Market Concentration Ratio
        3.4.1 Global Biopharmaceutical and Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccines Revenue in 2020
    3.5 Biopharmaceutical and Vaccines Key Players Head office and Area Served
    3.6 Key Players Biopharmaceutical and Vaccines Product Solution and Service
    3.7 Date of Enter into Biopharmaceutical and Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical and Vaccines Breakdown Data by Type
    4.1 Global Biopharmaceutical and Vaccines Historic Market Size by Type (2016-2021)
    4.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical and Vaccines Breakdown Data by Application
    5.1 Global Biopharmaceutical and Vaccines Historic Market Size by Application (2016-2021)
    5.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biopharmaceutical and Vaccines Market Size (2016-2027)
    6.2 North America Biopharmaceutical and Vaccines Market Size by Type
        6.2.1 North America Biopharmaceutical and Vaccines Market Size by Type (2016-2021)
        6.2.2 North America Biopharmaceutical and Vaccines Market Size by Type (2022-2027)
        6.2.3 North America Biopharmaceutical and Vaccines Market Size by Type (2016-2027)
    6.3 North America Biopharmaceutical and Vaccines Market Size by Application
        6.3.1 North America Biopharmaceutical and Vaccines Market Size by Application (2016-2021)
        6.3.2 North America Biopharmaceutical and Vaccines Market Size by Application (2022-2027)
        6.3.3 North America Biopharmaceutical and Vaccines Market Size by Application (2016-2027)
    6.4 North America Biopharmaceutical and Vaccines Market Size by Country
        6.4.1 North America Biopharmaceutical and Vaccines Market Size by Country (2016-2021)
        6.4.2 North America Biopharmaceutical and Vaccines Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biopharmaceutical and Vaccines Market Size (2016-2027)
    7.2 Europe Biopharmaceutical and Vaccines Market Size by Type
        7.2.1 Europe Biopharmaceutical and Vaccines Market Size by Type (2016-2021)
        7.2.2 Europe Biopharmaceutical and Vaccines Market Size by Type (2022-2027)
        7.2.3 Europe Biopharmaceutical and Vaccines Market Size by Type (2016-2027)
    7.3 Europe Biopharmaceutical and Vaccines Market Size by Application
        7.3.1 Europe Biopharmaceutical and Vaccines Market Size by Application (2016-2021)
        7.3.2 Europe Biopharmaceutical and Vaccines Market Size by Application (2022-2027)
        7.3.3 Europe Biopharmaceutical and Vaccines Market Size by Application (2016-2027)
    7.4 Europe Biopharmaceutical and Vaccines Market Size by Country
        7.4.1 Europe Biopharmaceutical and Vaccines Market Size by Country (2016-2021)
        7.4.2 Europe Biopharmaceutical and Vaccines Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size (2016-2027)
    8.2 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type
        8.2.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application
        8.3.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region
        8.4.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biopharmaceutical and Vaccines Market Size (2016-2027)
    9.2 Latin America Biopharmaceutical and Vaccines Market Size by Type
        9.2.1 Latin America Biopharmaceutical and Vaccines Market Size by Type (2016-2021)
        9.2.2 Latin America Biopharmaceutical and Vaccines Market Size by Type (2022-2027)
        9.2.3 Latin America Biopharmaceutical and Vaccines Market Size by Type (2016-2027)
    9.3 Latin America Biopharmaceutical and Vaccines Market Size by Application
        9.3.1 Latin America Biopharmaceutical and Vaccines Market Size by Application (2016-2021)
        9.3.2 Latin America Biopharmaceutical and Vaccines Market Size by Application (2022-2027)
        9.3.3 Latin America Biopharmaceutical and Vaccines Market Size by Application (2016-2027)
    9.4 Latin America Biopharmaceutical and Vaccines Market Size by Country
        9.4.1 Latin America Biopharmaceutical and Vaccines Market Size by Country (2016-2021)
        9.4.2 Latin America Biopharmaceutical and Vaccines Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size (2016-2027)
    10.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type
        10.2.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application
        10.3.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country
        10.4.1 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Details
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Biopharmaceutical and Vaccines Introduction
        11.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.1.5 Novartis Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Biopharmaceutical and Vaccines Introduction
        11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.2.5 Pfizer Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Biopharmaceutical and Vaccines Introduction
        11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.3.5 Sanofi Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Biopharmaceutical and Vaccines Introduction
        11.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 Abbott
        11.5.1 Abbott Company Details
        11.5.2 Abbott Business Overview
        11.5.3 Abbott Biopharmaceutical and Vaccines Introduction
        11.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.5.5 Abbott Recent Development
    11.6 Biogen Idec
        11.6.1 Biogen Idec Company Details
        11.6.2 Biogen Idec Business Overview
        11.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction
        11.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.6.5 Biogen Idec Recent Development
    11.7 Regeneron Pharmaceuticals
        11.7.1 Regeneron Pharmaceuticals Company Details
        11.7.2 Regeneron Pharmaceuticals Business Overview
        11.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction
        11.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.7.5 Regeneron Pharmaceuticals Recent Development
    11.8 Alexion Pharmaceuticals
        11.8.1 Alexion Pharmaceuticals Company Details
        11.8.2 Alexion Pharmaceuticals Business Overview
        11.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction
        11.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.8.5 Alexion Pharmaceuticals Recent Development
    11.9 Johnson and Johnson
        11.9.1 Johnson and Johnson Company Details
        11.9.2 Johnson and Johnson Business Overview
        11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction
        11.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.9.5 Johnson and Johnson Recent Development
    11.10 GlaxoSmithKline
        11.10.1 GlaxoSmithKline Company Details
        11.10.2 GlaxoSmithKline Business Overview
        11.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction
        11.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.10.5 GlaxoSmithKline Recent Development
    11.11 Merck
        11.11.1 Merck Company Details
        11.11.2 Merck Business Overview
        11.11.3 Merck Biopharmaceutical and Vaccines Introduction
        11.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.11.5 Merck Recent Development
    11.12 Lonza
        11.12.1 Lonza Company Details
        11.12.2 Lonza Business Overview
        11.12.3 Lonza Biopharmaceutical and Vaccines Introduction
        11.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.12.5 Lonza Recent Development
    11.13 Boehringer Ingelheim
        11.13.1 Boehringer Ingelheim Company Details
        11.13.2 Boehringer Ingelheim Business Overview
        11.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction
        11.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.13.5 Boehringer Ingelheim Recent Development
    11.14 Rentschler
        11.14.1 Rentschler Company Details
        11.14.2 Rentschler Business Overview
        11.14.3 Rentschler Biopharmaceutical and Vaccines Introduction
        11.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2016-2021)
        11.14.5 Rentschler Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Biopharmaceutical
    Table 3. Key Players of Vaccine Production
    Table 4. Global Biopharmaceutical and Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Biopharmaceutical and Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Biopharmaceutical and Vaccines Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Biopharmaceutical and Vaccines Market Share by Regions (2016-2021)
    Table 8. Global Biopharmaceutical and Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Biopharmaceutical and Vaccines Market Share by Regions (2022-2027)
    Table 10. Biopharmaceutical and Vaccines Market Trends
    Table 11. Biopharmaceutical and Vaccines Market Drivers
    Table 12. Biopharmaceutical and Vaccines Market Challenges
    Table 13. Biopharmaceutical and Vaccines Market Restraints
    Table 14. Global Biopharmaceutical and Vaccines Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Biopharmaceutical and Vaccines Market Share by Players (2016-2021)
    Table 16. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccines as of 2020)
    Table 17. Ranking of Global Top Biopharmaceutical and Vaccines Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccines Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Biopharmaceutical and Vaccines Product Solution and Service
    Table 21. Date of Enter into Biopharmaceutical and Vaccines Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2016-2021)
    Table 25. Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Biopharmaceutical and Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2016-2021)
    Table 29. Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Biopharmaceutical and Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Biopharmaceutical and Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Biopharmaceutical and Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Biopharmaceutical and Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Biopharmaceutical and Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Biopharmaceutical and Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Biopharmaceutical and Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Biopharmaceutical and Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Biopharmaceutical and Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Biopharmaceutical and Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Biopharmaceutical and Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Biopharmaceutical and Vaccines Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Biopharmaceutical and Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Biopharmaceutical and Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Biopharmaceutical and Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Biopharmaceutical and Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Biopharmaceutical and Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Biopharmaceutical and Vaccines Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Novartis Company Details
    Table 62. Novartis Business Overview
    Table 63. Novartis Biopharmaceutical and Vaccines Product
    Table 64. Novartis Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 65. Novartis Recent Development
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Biopharmaceutical and Vaccines Product
    Table 69. Pfizer Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. Sanofi Company Details
    Table 72. Sanofi Business Overview
    Table 73. Sanofi Biopharmaceutical and Vaccines Product
    Table 74. Sanofi Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 75. Sanofi Recent Development
    Table 76. Roche Company Details
    Table 77. Roche Business Overview
    Table 78. Roche Biopharmaceutical and Vaccines Product
    Table 79. Roche Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 80. Roche Recent Development
    Table 81. Abbott Company Details
    Table 82. Abbott Business Overview
    Table 83. Abbott Biopharmaceutical and Vaccines Product
    Table 84. Abbott Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 85. Abbott Recent Development
    Table 86. Biogen Idec Company Details
    Table 87. Biogen Idec Business Overview
    Table 88. Biogen Idec Biopharmaceutical and Vaccines Product
    Table 89. Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 90. Biogen Idec Recent Development
    Table 91. Regeneron Pharmaceuticals Company Details
    Table 92. Regeneron Pharmaceuticals Business Overview
    Table 93. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product
    Table 94. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 95. Regeneron Pharmaceuticals Recent Development
    Table 96. Alexion Pharmaceuticals Company Details
    Table 97. Alexion Pharmaceuticals Business Overview
    Table 98. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 99. Alexion Pharmaceuticals Recent Development
    Table 100. Johnson and Johnson Company Details
    Table 101. Johnson and Johnson Business Overview
    Table 102. Johnson and Johnson Biopharmaceutical and Vaccines Product
    Table 103. Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 104. Johnson and Johnson Recent Development
    Table 105. GlaxoSmithKline Company Details
    Table 106. GlaxoSmithKline Business Overview
    Table 107. GlaxoSmithKline Biopharmaceutical and Vaccines Product
    Table 108. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 109. GlaxoSmithKline Recent Development
    Table 110. Merck Company Details
    Table 111. Merck Business Overview
    Table 112. Merck Biopharmaceutical and Vaccines Product
    Table 113. Merck Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 114. Merck Recent Development
    Table 115. Lonza Company Details
    Table 116. Lonza Business Overview
    Table 117. Lonza Biopharmaceutical and Vaccines Product
    Table 118. Lonza Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 119. Lonza Recent Development
    Table 120. Boehringer Ingelheim Company Details
    Table 121. Boehringer Ingelheim Business Overview
    Table 122. Boehringer Ingelheim Biopharmaceutical and Vaccines Product
    Table 123. Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 124. Boehringer Ingelheim Recent Development
    Table 125. Rentschler Company Details
    Table 126. Rentschler Business Overview
    Table 127. Rentschler Biopharmaceutical and Vaccines Product
    Table 128. Rentschler Revenue in Biopharmaceutical and Vaccines Business (2016-2021) & (US$ Million)
    Table 129. Rentschler Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceutical and Vaccines Market Share by Type: 2020 VS 2027
    Figure 2. Biopharmaceutical Features
    Figure 3. Vaccine Production Features
    Figure 4. Global Biopharmaceutical and Vaccines Market Share by Application: 2020 VS 2027
    Figure 5. Pharmaceuticals Industry Case Studies
    Figure 6. Clinical Diagnosis Case Studies
    Figure 7. Scientific Research Case Studies
    Figure 8. Others Case Studies
    Figure 9. Biopharmaceutical and Vaccines Report Years Considered
    Figure 10. Global Biopharmaceutical and Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Biopharmaceutical and Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Biopharmaceutical and Vaccines Market Share by Regions: 2020 VS 2027
    Figure 13. Global Biopharmaceutical and Vaccines Market Share by Regions (2022-2027)
    Figure 14. Global Biopharmaceutical and Vaccines Market Share by Players in 2020
    Figure 15. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccines as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2020
    Figure 17. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2016-2021)
    Figure 18. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2022-2027)
    Figure 19. North America Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Biopharmaceutical and Vaccines Market Share by Type (2016-2027)
    Figure 21. North America Biopharmaceutical and Vaccines Market Share by Application (2016-2027)
    Figure 22. North America Biopharmaceutical and Vaccines Market Share by Country (2016-2027)
    Figure 23. United States Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Biopharmaceutical and Vaccines Market Share by Type (2016-2027)
    Figure 27. Europe Biopharmaceutical and Vaccines Market Share by Application (2016-2027)
    Figure 28. Europe Biopharmaceutical and Vaccines Market Share by Country (2016-2027)
    Figure 29. Germany Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Biopharmaceutical and Vaccines Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Biopharmaceutical and Vaccines Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Biopharmaceutical and Vaccines Market Share by Region (2016-2027)
    Figure 39. China Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Biopharmaceutical and Vaccines Market Share by Type (2016-2027)
    Figure 47. Latin America Biopharmaceutical and Vaccines Market Share by Application (2016-2027)
    Figure 48. Latin America Biopharmaceutical and Vaccines Market Share by Country (2016-2027)
    Figure 49. Mexico Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Biopharmaceutical and Vaccines Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Biopharmaceutical and Vaccines Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Biopharmaceutical and Vaccines Market Share by Country (2016-2027)
    Figure 55. Turkey Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Biopharmaceutical and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 59. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 60. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 62. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 63. Biogen Idec Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 64. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 65. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 66. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 67. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 68. Merck Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 69. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 70. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 71. Rentschler Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Frequently Asked Questions
Biopharmaceutical and Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceutical and Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceutical and Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DNA Vaccination

DNA vaccination is a technique for protecting against disease by injection with genetically engin ... Read More